A double-blind, placebo controlled multicentre study to evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis.

Abstract

EudraCT Number: 2004-002571-16
Sponsor Protocol Number: MBP8298-01 Amendment 04
Sponsor Name: BioMS Technology Corp
Start Date: 2007-06-29
Medical condition: Secondary progressive multiple sclerosis
Disease:
Version: 8.1
SOC Term:
Classification Code: 10063400
Term: Secondary progressive multiple sclerosis
Level: LLT

Population Age: Adults
Gender: Male, Female
Trial Protocol: GB (Completed), SE (Completed), FI (Completed), DK (Completed), ES (Completed), EE (Completed), NL (Completed), LT (Prematurely Ended), LV (Completed)